Healthcare -
Biotechnology - NASDAQ - US
$ 2.07
-12.1 %
$ 3.4 M
Market Cap
-0.19
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Ensysce Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 11.9 |
| Operating Income | (6.73) |
| Other Expenses | (6.73) |
| Net Income | -7.99 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 2.2 | 2.5 | 3.5 | 3.9 | 1.8 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 7.6 | 19.8 | 151 | 1.4 | 3.3 | 1.6 | 0 |
| Gross Profit | 0 | (5.4) | (17.3) | 3.5 | 2.6 | (1.6) | (1.6) | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 11 940 165.0 | 5.4 | 24.2 | 19.9 | 1.6 | 3.3 | 1.0 | 0.1 |
| Selling, General and Administrative Expenses | 4 720 728.0 | 5.4 | 6.9 | 18.7 | 1.2 | 3.3 | 1.6 | 0.1 |
| Research and Development Expenses | 7 219 437.0 | 7.6 | 19.8 | 4.7 | 4.4 | 3.4 | 0 | 0 |
| Operating Income | (6 730 134.0) | (10.7) | (24.2) | (19.9) | (1.6) | (3.3) | (1.0) | (0.1) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | (1 290 444.0) | 0.4 | 0.1 | 1.3 | 1.0 | 0 | 0 | 0 |
| Total Other Income | (1 257 091.0) | 91.9 K | 14.4 K | (9.3) | 1.5 | 4.2 | 3.6 | 0.1 |
| Pre-Tax Income | (7 987 225.0) | (10.6) | (24.2) | (29.1) | (0.2) | 0.9 | 2.7 | 27.6 K |
| NET INCOME | ||||||||
| Tax Provision | 0 | 0 | 0.8 | 151 | 0.8 | (0.6) | 0.6 | 3.64 K |
| Net Income | (7 987 225.0) | (10.6) | (25.0) | (29.1) | (0.9) | 1.5 | (1.3) | 31.2 K |
| EPS | (4.6) | 4.69 | 139 | 347 | 14.3 | 0.24 | 0.22 | 0.0052 |